Intas Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 1985.
1985 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Intas Pharmaceuticals Limited

Intas Pharmaceuticals Limited, a active public limited company, was established on 31 May 1985 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1985PLC007866. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹175.47 Cr and a paid-up capital of ₹114.77 Cr.

Formerly known as Intas Laboratories Private Limited. It upholds a compliant status. Employing 19,974 professional, Its leadership includes Urmish Hasmukh Chudgar (Managing Director), Hasmukh Chudgar (Director), Archana Ravindrarai Dholakia (Director). Past directors included Hemant Devidas Sheth, Kusumben Hasmukhbhai Chudgar, Sanjiv Dwarkanath Kaul. It holds ₹4.50 Cr open charges and ₹7,924.94 Cr settled loans. Its latest AGM occurred on 08 September 2025, with the balance sheet filed on 31 March 2025. It is based at Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ1985PLC007866

  • Registration Number

    007866

  • Incorporation Date

    31 May 1985

  • Authorized Capital

    ₹175.47 Cr

  • Paid-Up Capital

    ₹114.77 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 175.47 Cr
  • Paid Up Capital ₹ 114.77 Cr
  • Company Age 40 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.50 Cr
  • Satisfied Charges ₹ 7,924.94 Cr
  • Revenue Growth **** -3.44%
  • Profit Growth **** -17.74%
  • Ebitda **** -18.86%
  • Net Worth 13.06%
  • Total Assets **** 8.17%
Company report

Intas Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Intas Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Intas Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Urmish Hasmukh Chudgar Managing Director 30 Sep 1996 Current
Hasmukh Chudgar Director 31 May 1985 Current
Archana Ravindrarai Dholakia Director 14 Jun 2023 Current
Jayesh Shantilal Shah Whole-Time Director 21 Mar 2018 Current
Venkatesh Ratnasami Nominee Director 13 Nov 2014 Current
Binish Hasmukh Chudgar Managing Director 31 May 1985 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Sep 2019 Past
Pramod Abcsdd Additional Director 10 Aug 2015 Past
Pramod Abcsdd Nominee Director 13 Jan 2020 Past
Pramod Abcsdd Whole-Time Director 11 Mar 2015 Past
Pramod Abcsdd Cfo(Kmp) 30 Nov 2022 Past
Pramod Abcsdd Additional Director 12 Aug 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Intas Pharmaceuticals.

Intas Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.44% decrease. The company also saw a substantial fall in profitability, with a 17.74% decrease in profit. The company's net worth Soared by an impressive increase of 13.06%.

Intas Pharmaceuticals revenue growth over time
Intas Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -3.44%
*******
*******
*******
*******
Revenue from Operations
*******
 -4.33%
*******
*******
*******
*******
Total Assets
*******
 8.17%
*******
*******
*******
*******
Profit or Loss
*******
 -17.74%
*******
*******
*******
*******
Net Worth
*******
 13.06%
*******
*******
*******
*******
EBITDA
*******
 -18.86%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Intas Pharmaceuticals?

In 2024, Intas Pharmaceuticals had a promoter holding of 83.84% and a public holding of 16.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹45,000,000.00

Satisfied Charges

₹79,249,379,660.29

Charges Breakdown by Lending Institutions
  • Dena Bank : 4.50 Cr
Latest Charge Details
Date Lender Amount Status
01 May 1998 Dena Bank ₹4.50 Cr Open
04 Sep 2017 Standard Chartered Bank ₹184.62 Cr Satisfied
28 Dec 2016 Others ₹3,218.29 Cr Satisfied
28 Dec 2016 Others ₹1,845.87 Cr Satisfied
21 Mar 2016 Citi Bank N.A. ₹115.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Intas Pharmaceuticals?

Intas Pharmaceuticals has a workforce of 19974 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Intas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intas Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Intas Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Intas Pharmaceuticals Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Intas Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Abhimanyu Ojha was appointed as a Cfo was appointed as a Cfo on 11 Oct 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.

  • Charges

    A charge registered on 25 Jun 1999 via Charge ID 90103163 with Others was fully satisfied on 01 Oct 2024. was recorded as a recent event.

  • Director Appointment

    The activity Jitesh Kishorekumar Gadhia was appointed as a Additional Director was appointed as a Additional Director on 19 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.

  • Director Appointment

    Archana Ravindrarai Dholakia was appointed as a Director was appointed as a Director on 14 Jun 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Intas Pharmaceuticals Limited?

The CIN of Intas Pharmaceuticals Limited is U24231GJ1985PLC007866.

Where is Intas Pharmaceuticals Limited headquartered?

Intas Pharmaceuticals Limited is headquartered at Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad, Gujarat, 380054.

When was Intas Pharmaceuticals Limited incorporated?

Intas Pharmaceuticals Limited was incorporated on 31 May 1985.

Who are the current directors of Intas Pharmaceuticals Limited?

The current directors of Intas Pharmaceuticals Limited are

What is the primary industry of Intas Pharmaceuticals Limited?

The primary industry of Intas Pharmaceuticals Limited is Manufacturing.

Is Intas Pharmaceuticals Limited a listed company?

Intas Pharmaceuticals Limited is unlisted.

What is the capital structure of Intas Pharmaceuticals Limited?

The authorized capital of Intas Pharmaceuticals Limited is ₹175.47 Cr, and the paid-up capital is ₹114.77 Cr.

What is the compliance status of Intas Pharmaceuticals Limited?

The compliance status of Intas Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available